1 completed, 1 terminated. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Brimonidine 0.33% gel: new trials by email Literature Review of Brimonidine 0.33% gel trials Research Report on Brimonidine 0.33% gel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brimonidine 0.33% for Rosacea-Related Facial Erythema Brimonidine 0.33% gel, Placebo gel - Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic) | Phase 4 | Completed | Istanbul Training and Research Hospital | 45 | 2025-05-01 | 2026-02-24 |
| Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations Brimonidine 0.33% gel - Capillary Malformations | Phase 3 | Terminated | The Hospital for Sick Children | 6 | 2016-06-01 | 2019-04-16 |
Capillary Malformations, Congenital, 1 (1) · Depression (1) · Port-Wine Stain (1) · Rosacea (1) · Telangiectasis (1)
Istanbul Training and Research Hospital (1) · The Hospital for Sick Children (1)
Canada (1) · Turkey (Türkiye) (1)
Elena Pope, MD (1)